BRI-CHEM CORP (BRY.CA) Fundamental Analysis & Valuation

TSX:BRYCA10778T1057

Current stock price

0.35 CAD
-0.01 (-2.78%)
Last:

This BRY.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. BRY.CA Profitability Analysis

1.1 Basic Checks

  • In the past year BRY was profitable.
  • In the past year BRY had a positive cash flow from operations.
  • BRY had positive earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: BRY reported negative operating cash flow in multiple years.
BRY.CA Yearly Net Income VS EBIT VS OCF VS FCFBRY.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

1.2 Ratios

  • BRY has a Return On Assets of 2.26%. This is in the lower half of the industry: BRY underperforms 75.00% of its industry peers.
  • Looking at the Return On Equity, with a value of 4.83%, BRY is doing worse than 66.67% of the companies in the same industry.
  • BRY has a Return On Invested Capital of 6.39%. This is in the lower half of the industry: BRY underperforms 66.67% of its industry peers.
Industry RankSector Rank
ROA 2.26%
ROE 4.83%
ROIC 6.39%
ROA(3y)-1.01%
ROA(5y)2.18%
ROE(3y)-3.59%
ROE(5y)7.74%
ROIC(3y)N/A
ROIC(5y)N/A
BRY.CA Yearly ROA, ROE, ROICBRY.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • BRY's Profit Margin of 1.30% is on the low side compared to the rest of the industry. BRY is outperformed by 83.33% of its industry peers.
  • In the last couple of years the Profit Margin of BRY has declined.
  • With a Operating Margin value of 3.35%, BRY is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
  • BRY's Operating Margin has declined in the last couple of years.
  • BRY's Gross Margin of 19.23% is in line compared to the rest of the industry. BRY outperforms 50.00% of its industry peers.
  • BRY's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.35%
PM (TTM) 1.3%
GM 19.23%
OM growth 3Y-23.74%
OM growth 5YN/A
PM growth 3Y-46.01%
PM growth 5YN/A
GM growth 3Y-1.61%
GM growth 5Y3.55%
BRY.CA Yearly Profit, Operating, Gross MarginsBRY.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

4

2. BRY.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BRY is destroying value.
  • Compared to 1 year ago, BRY has about the same amount of shares outstanding.
  • Compared to 5 years ago, BRY has more shares outstanding
  • Compared to 1 year ago, BRY has an improved debt to assets ratio.
BRY.CA Yearly Shares OutstandingBRY.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
BRY.CA Yearly Total Debt VS Total AssetsBRY.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • An Altman-Z score of 1.82 indicates that BRY is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 1.82, BRY is doing worse than 83.33% of the companies in the same industry.
  • The Debt to FCF ratio of BRY is 1.43, which is an excellent value as it means it would take BRY, only 1.43 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of BRY (1.43) is better than 91.67% of its industry peers.
  • A Debt/Equity ratio of 0.41 indicates that BRY is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.41, BRY is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 1.43
Altman-Z 1.82
ROIC/WACC0.58
WACC10.98%
BRY.CA Yearly LT Debt VS Equity VS FCFBRY.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

2.3 Liquidity

  • BRY has a Current Ratio of 1.22. This is a normal value and indicates that BRY is financially healthy and should not expect problems in meeting its short term obligations.
  • BRY has a worse Current ratio (1.22) than 83.33% of its industry peers.
  • A Quick Ratio of 0.43 indicates that BRY may have some problems paying its short term obligations.
  • BRY's Quick ratio of 0.43 is on the low side compared to the rest of the industry. BRY is outperformed by 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.43
BRY.CA Yearly Current Assets VS Current LiabilitesBRY.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

3

3. BRY.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 125.12% over the past year.
  • BRY shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -51.82% yearly.
  • BRY shows a decrease in Revenue. In the last year, the revenue decreased by -8.99%.
  • The Revenue has been growing by 10.84% on average over the past years. This is quite good.
EPS 1Y (TTM)125.12%
EPS 3Y-51.82%
EPS 5YN/A
EPS Q2Q%167.57%
Revenue 1Y (TTM)-8.99%
Revenue growth 3Y-10.23%
Revenue growth 5Y10.84%
Sales Q2Q%-17.73%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BRY.CA Yearly Revenue VS EstimatesBRY.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

5

4. BRY.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 8.75 indicates a reasonable valuation of BRY.
  • Based on the Price/Earnings ratio, BRY is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.35. BRY is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.75
Fwd PE N/A
BRY.CA Price Earnings VS Forward Price EarningsBRY.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BRY indicates a rather cheap valuation: BRY is cheaper than 100.00% of the companies listed in the same industry.
  • BRY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BRY is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.88
EV/EBITDA 4.5
BRY.CA Per share dataBRY.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. BRY.CA Dividend Analysis

5.1 Amount

  • No dividends for BRY!.
Industry RankSector Rank
Dividend Yield 0%

BRY.CA Fundamentals: All Metrics, Ratios and Statistics

BRI-CHEM CORP

TSX:BRY (4/27/2026, 7:00:00 PM)

0.35

-0.01 (-2.78%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)03-25
Earnings (Next)05-18
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap9.25M
Revenue(TTM)75.60M
Net Income(TTM)979.10K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.75
Fwd PE N/A
P/S 0.12
P/FCF 0.88
P/OCF 0.84
P/B 0.46
P/tB 0.46
EV/EBITDA 4.5
EPS(TTM)0.04
EY11.43%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.4
FCFY114.21%
OCF(TTM)0.42
OCFY119.31%
SpS2.86
BVpS0.77
TBVpS0.77
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.831042 (137.44%)
Profitability
Industry RankSector Rank
ROA 2.26%
ROE 4.83%
ROCE 12.35%
ROIC 6.39%
ROICexc 6.39%
ROICexgc 6.39%
OM 3.35%
PM (TTM) 1.3%
GM 19.23%
FCFM 13.97%
ROA(3y)-1.01%
ROA(5y)2.18%
ROE(3y)-3.59%
ROE(5y)7.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-11.74%
ROICexgc growth 5YN/A
ROICexc growth 3Y-11.74%
ROICexc growth 5YN/A
OM growth 3Y-23.74%
OM growth 5YN/A
PM growth 3Y-46.01%
PM growth 5YN/A
GM growth 3Y-1.61%
GM growth 5Y3.55%
F-Score7
Asset Turnover1.74
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 1.43
Debt/EBITDA 2.25
Cap/Depr 41.07%
Cap/Sales 0.62%
Interest Coverage 1.02
Cash Conversion 299.56%
Profit Quality 1079.03%
Current Ratio 1.22
Quick Ratio 0.43
Altman-Z 1.82
F-Score7
WACC10.98%
ROIC/WACC0.58
Cap/Depr(3y)42.3%
Cap/Depr(5y)64.95%
Cap/Sales(3y)0.59%
Cap/Sales(5y)0.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)125.12%
EPS 3Y-51.82%
EPS 5YN/A
EPS Q2Q%167.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.99%
Revenue growth 3Y-10.23%
Revenue growth 5Y10.84%
Sales Q2Q%-17.73%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y410.75%
EBIT growth 3Y-31.54%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y5.94%
FCF growth 3YN/A
FCF growth 5Y0.67%
OCF growth 1Y6.26%
OCF growth 3YN/A
OCF growth 5Y1.55%

BRI-CHEM CORP / BRY.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BRI-CHEM CORP?

ChartMill assigns a fundamental rating of 3 / 10 to BRY.CA.


Can you provide the valuation status for BRI-CHEM CORP?

ChartMill assigns a valuation rating of 5 / 10 to BRI-CHEM CORP (BRY.CA). This can be considered as Fairly Valued.


How profitable is BRI-CHEM CORP (BRY.CA) stock?

BRI-CHEM CORP (BRY.CA) has a profitability rating of 2 / 10.


What are the PE and PB ratios of BRI-CHEM CORP (BRY.CA) stock?

The Price/Earnings (PE) ratio for BRI-CHEM CORP (BRY.CA) is 8.75 and the Price/Book (PB) ratio is 0.46.